Ben J. Liu

Qingchun Road 79
Hangzhou, 310003, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 71 publications

RNA N4-acetylcytidine modification in human cancers: from molecular function to oncogenic mechanisms.

RNA N4-acetylcytidine modification in human cancers: from molecular function to oncogenic mechanisms.

Journal: iScience

Published: March 09, 2026

The tumor promoter role and molecular mechanism of C8orf76/CALB2 axis in clear cell renal cell carcinoma.

The tumor promoter role and molecular mechanism of C8orf76/CALB2 axis in clear cell renal cell carcinoma.

Journal: iScience

Published: October 22, 2025

piR-43452 suppresses bladder cancer progression and enhances gemcitabine sensitivity via GTSF1/PIWIL4-mediated LRP1 mRNA destabilization.

piR-43452 suppresses bladder cancer progression and enhances gemcitabine sensitivity via GTSF1/PIWIL4-mediated LRP1 mRNA destabilization.

Journal: Translational oncology

Published: October 03, 2025

YTHDF3 at the crossroads of the Epitranscriptome: Structure, networks, and disease roles.

YTHDF3 at the crossroads of the Epitranscriptome: Structure, networks, and disease roles.

Journal: Cellular signalling

Published: September 21, 2025

Lactylation enhances YTHDF3 stability to promote cisplatin resistance via m6A-dependent KDM6B decay in bladder cancer.

Lactylation enhances YTHDF3 stability to promote cisplatin resistance via m6A-dependent KDM6B decay in bladder cancer.

Journal: Cancer letters

Published: September 15, 2025

Histone deacetylase HDAC7 restricts CD8 + T cell tumor infiltration and limits immunotherapy sensitivity in bladder cancer: reversal by pinocembrin.

Histone deacetylase HDAC7 restricts CD8 + T cell tumor infiltration and limits immunotherapy sensitivity in bladder cancer: reversal by pinocembrin.

Journal: Journal of experimental & clinical cancer research : CR

Published: July 30, 2025

Hypoxia-Induced Histone Lactylation Drives Cisplatin Resistance in Bladder Cancer by Promoting RBM15-Dependent m6A Methylation of IGFBP3.

Hypoxia-Induced Histone Lactylation Drives Cisplatin Resistance in Bladder Cancer by Promoting RBM15-Dependent m6A Methylation of IGFBP3.

Journal: Research (Washington, D.C.)

Published: July 25, 2025

GLI2/Parkin-mediated mitophagy promotes pazopanib resistance in clear cell renal cell carcinoma.

GLI2/Parkin-mediated mitophagy promotes pazopanib resistance in clear cell renal cell carcinoma.

Journal: Cellular signalling

Published: March 29, 2025

SREBF1-mediated SND1 transcriptional activation promotes prostate cancer progression via MTDH interaction through the SESN2/AMPK/mTOR axis.

SREBF1-mediated SND1 transcriptional activation promotes prostate cancer progression via MTDH interaction through the SESN2/AMPK/mTOR axis.

Journal: Journal of translational medicine

Published: February 11, 2025

KIF26B promotes bladder cancer progression via activating Wnt/β-catenin signaling in a TRAF2-dependent pathway.

KIF26B promotes bladder cancer progression via activating Wnt/β-catenin signaling in a TRAF2-dependent pathway.

Journal: Cell reports

Published: October 29, 2024

Clinical assessment of urinary prostate cancer antigen 3 in Chinese population: a large-scale, prospective and multicenter study.

Clinical assessment of urinary prostate cancer antigen 3 in Chinese population: a large-scale, prospective and multicenter study.

Journal: World journal of surgical oncology

Published: September 25, 2024

"Three-in-one" Analysis of Proteinuria for Disease Diagnosis through Multifunctional Nanoparticles and Machine Learning.

"Three-in-one" Analysis of Proteinuria for Disease Diagnosis through Multifunctional Nanoparticles and Machine Learning.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: September 09, 2024

Showing 1-12 of 71

Last Updated: 09/26/2026